Auna S A 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Auna S A in the fourth quarter 2025?
Auna S a achieved a return on average equity (ROE) of 10.61 % in its fourth quarter 2025, this is above AUNA's average return on equity of 6.28%.
Auna S A shareholder's equity over the 12 months ending in its fourth quarter 2025 are valued at $535 million

ROE has advanced compared to 4.95% in the third quarter 2025, due to net income growth.

Within the Healthcare Facilities industry 24 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 2130.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) II. Quarter
Y / Y Equity Change	21 %	11.5 %	30.02 %	-	-
Y / Y Net Income Change	1474.35 %	-	-	-	-
Net Income (TTM) in Millions	57	25	25	2	2
Return On Equity (TTM)	10.61 %	4.95 %	5.08 %	0.46 %	0.64 %
AUNA's Total Ranking	# 2130	#	#	#	#
Equity (TTM) in Millions	535	535	535	535	442
Seq. Equity Change	0 %	0 %	0 %	21 %	-7.85 %
Seq. Net Income Change	-	-	-	-	-

Back to AUNA Management Effectiveness >> AUNA's 5 Years Annual ROE >> Compare AUNA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 25
Sector	# 184
Overall	# 2130

Return On Equity Statistics
High	Average	Low
6.28 %	6.28 %	6.28 %
(Dec 31 2025)

AUNA Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2022) 2024
Total Equity in Millions	535	442	0	0	0
Y / Y Equity Change	21 %	-	-	-	-
Net Income in Millions	34	33	0	0	0
Y / Y Net Income Change	0.87 %	-	-	-	-
Return On Equity	6.28 %	7.53 %	-	-	-

Back to AUNA Management Effectiveness >> AUNA's 5 Years Annual ROE >> Compare AUNA ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 6.28 %, despite net income growth.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AUNA's' Return on Equity at Yahoo Finance
AUNA's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AUNA's Competitors
Subscribers only: Roe for Auna S A 's Suppliers
Subscribers only: Return On Equity for AUNA's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Incyte Corporation	29.15 %
Waters Corporation	28.52 %
Puma Biotechnology Inc	27.81 %
Resmed Inc	25.18 %
Encompass Health Corporation	24.76 %
Prestige Consumer Healthcare Inc	24.66 %
Catalyst Pharmaceuticals Inc	24.32 %
Collegium Pharmaceutical Inc	24.11 %
Xoma Royalty Corporation	23.97 %
Chemed Corporation	23.92 %
Iradimed Corporation	23.83 %
Lifevantage Corp	23.04 %
Hims and Hers Health Inc	22.99 %
Vertex Pharmaceuticals Inc	22.70 %
Pacs Group Inc	22.54 %
Spero Therapeutics Inc	22.53 %
Iqvia Holdings Inc	22.05 %
Ge Healthcare Technologies Inc	21.90 %
Msa Safety Inc	21.82 %
Mimedx Group Inc	21.24 %
Universal Health Services Inc	21.19 %
Inspire Medical Systems inc	21.07 %
Astrazeneca Plc	21.00 %
Haemonetics Corporation	20.80 %
Sbc Medical Group Holdings Incorporated	20.79 %
Lantheus Holdings Inc	20.58 %
Electromed Inc	20.54 %
Teva Pharmaceutical Industries Limited	20.07 %
Harmony Biosciences Holdings inc	19.84 %
Pediatrix Medical Group Inc	19.58 %

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.